These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 82610)

  • 1. Effect of trypsin treatment on the antigenic characteristics of plaque variants of type-O 1 and type Asia-1 foot-and-mouth disease viruses.
    Cowan KM; Erol N; Whiteland AP
    J Gen Virol; 1978 Nov; 41(2):437-42. PubMed ID: 82610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of trypsin and chymotrypsin on the polypeptides of large and small plaque variants of foot-and-mouth disease virus: relationship to specific antigenicity and infectivity.
    Moore DM; Cowan KM
    J Gen Virol; 1978 Dec; 41(3):549-62. PubMed ID: 84854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of trypsin-resistant O1 variants of foot-and-mouth disease virus.
    Barteling SJ; Meloen RH; Wagenaar F; Gielkens AL
    J Gen Virol; 1979 May; 43(2):383-93. PubMed ID: 225425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of trypsin-sensitive antigenic determinants common to the intact virus particle and the 12S subunit of the Uga 6/70 strain of foot-and-mouth disease virus type SAT 2.
    Booth JC
    J Gen Virol; 1977 Mar; 34(3):551-5. PubMed ID: 67182
    [No Abstract]   [Full Text] [Related]  

  • 5. Alteration of the trypsin-sensitive antigenic site of foot-and-mouth disease virus following direct binding to an ELISA plate.
    Pattnaik B; Venkataramanan R; Mukhopadhyaya AK
    J Immunol Methods; 1996 Jun; 192(1-2):195-7. PubMed ID: 8699018
    [No Abstract]   [Full Text] [Related]  

  • 6. Host cell selection of antigenic variants of foot-and-mouth disease virus.
    Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of the antigenic structure of foot-and-mouth disease virus to the process of infection.
    Rowlands DJ; Sangar DV; Brown F
    J Gen Virol; 1971 Oct; 13(1):85-93. PubMed ID: 4331815
    [No Abstract]   [Full Text] [Related]  

  • 8. [Several criteria of evaluation of foot-and-mouth disease virus reproduced in cell cultures in suspension].
    Girard HC
    Dev Biol Stand; 1976; 35():91-6. PubMed ID: 71255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response against foot and mouth disease virus (FMDV). Part II: Responses measured in fractionated sera of infected steers with complete virus, trypsin treated virus, 12 S virus subunits, VIA and heterologous virus.
    Meloen RH
    Zentralbl Veterinarmed B; 1979 Jul; 26(5):358-65. PubMed ID: 93833
    [No Abstract]   [Full Text] [Related]  

  • 10. Localisation on foot-and-mouth disease virus (FMDV) of an antigenic deficiency induced by passage in BHK cells.
    Meloen RH
    Arch Virol; 1976; 51(4):299-306. PubMed ID: 184763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemagglutination by type SAT 2 foot-and-mouth disease viruses.
    Booth JC; Pay TW
    J Gen Virol; 1973 Jun; 19(3):397-404. PubMed ID: 4353214
    [No Abstract]   [Full Text] [Related]  

  • 12. Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an in situ assay.
    Diez J; Mateu MG; Domingo E
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3281-9. PubMed ID: 2481712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Routine physico-chemical testing of concentrated virulent and inactivated foot-and-mouth disease virus antigens].
    Adamowicz P; Guerche J; Galampoix J; Prunet P
    Dev Biol Stand; 1976; 35():301-10. PubMed ID: 198300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of variation in trypsin-sensitive neutralizable antigenic site of type O foot-and-mouth disease virus (FMDV) isolates using a Mab-binding inhibition assay.
    Pattnaik B; Jadhao SJ; Venkataramanan R; Mukhopadhyay AK
    J Immunol Methods; 1996 Jun; 192(1-2):191-3. PubMed ID: 8699017
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenically profound amino acid substitutions occur during large population passages of foot-and-mouth disease virus.
    Sevilla N; Verdaguer N; Domingo E
    Virology; 1996 Nov; 225(2):400-5. PubMed ID: 8918927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI.
    Meloen RH; Briaire J; Woortmeyer RJ; van Zaane D
    J Gen Virol; 1983 May; 64(Pt 5):1193-8. PubMed ID: 6188800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence identification of antigenic variants in plaque isolates of foot-and-mouth disease virus.
    Meyer RF; Brown F
    J Virol Methods; 1995 Oct; 55(2):281-3. PubMed ID: 8537465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three variants of foot-and-mouth disease virus type O: cell culture characteristics and antigenic differences.
    McVicar JW; Sutmoller P
    Am J Vet Res; 1972 Aug; 33(8):1627-33. PubMed ID: 4340052
    [No Abstract]   [Full Text] [Related]  

  • 19. Plaque enhancement effect of sodium thiosulfate for foot-and-mouth disease viruses.
    Kadoi K
    Microbiologica; 1986 Apr; 9(2):151-62. PubMed ID: 3012288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of neutralizing and non-neutralizing epitopes on the trypsin-sensitive site of foot-and-mouth disease virus.
    Ouldridge EJ; Barnett PV; Parry NR; Syred A; Head M; Rweyemamu MM
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():203-7. PubMed ID: 6198448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.